{
    "2018-07-03": [
        [
            {
                "time": "2018-07-02",
                "original_text": "【金融工程】唐军：中泰金工事件驱动周报主营产品涨价及冷门股效应-20180702",
                "features": {
                    "keywords": [
                        "主营产品涨价",
                        "冷门股效应",
                        "中泰金工"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "医药生物行业2018年中期策略:创新为本,精选优质龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新",
                        "优质龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "[推荐评级]医药行业2018年7月份投资月报：风雨后见彩虹 积极布局中报行情",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资月报",
                        "中报行情"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "华大基因大涨7.81%，报103.90元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "[推荐评级]医药行业周报：长期配置核心资产 短期关注高速个股的估值切换",
                "features": {
                    "keywords": [
                        "医药行业",
                        "核心资产",
                        "估值切换"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "[推荐评级]医药行业周报：关注中报业绩 选择估值合理标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报业绩",
                        "估值合理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "机构、股东、高管争相买入这些业绩暴增股",
                "features": {
                    "keywords": [
                        "机构",
                        "股东",
                        "高管",
                        "业绩暴增"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "医药生物行业业绩研究预报",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}